This latest PR only describes the pre-liminary res

This latest PR only describes the pre-liminary results. It will take at least another two weeks to put all the data together and make a final analysis. I would say it is premature to say Syneos has made a decision to not move forward with Leronlimab. I would think that no one will make a decision on this matter until after the final data analysis is compiled and sent to CYDY management. We are probably looking at the next 3 weeks before any such announcement would be forthcoming. JMHO.